Jump to Navigation
Home

Main menu

  • Home
  • News
  • Markets Map
  • Sentiments
  • Topics
  • Data
  • Comments
  • Images
  • Blog
  • About

Secondary menu

  • Latest News
  • Top Rated
  • Most Popular
  • Archive
  • Discussions
  • US issuers continue assault of Europe's ETF market
  • Exclusive: Glencore, Trafigura deals with Iran may have...
  • Daily Mail publisher's print revenues slide
  • SOE profits rise in first 4 months
  • Business news and markets: live
  • Markets fall on China data, Fed
  • Weak PMI data drags down Chinese shares
  • Grexit No Longer Likely, Says Man Who Coined Phrase
  • AMD Launches 'Kabini' And 'Temash' -...
  • Japan's Breathtaking 7% Plunge Is The Worst Since...

    Sequanon’s Test for Down Syndrome Raises Hopes and Questions

    Mon, 10/17/2011 - 11:14 EDT - NY Times
    • Amniocentesis
    • Down Syndrome
    • Genetics and Heredity
    • Tests (Medical)

    While the test may reduce the need for riskier invasive procedures such as amniocentesis, it also raises ethical issues.

    • Original article
    • Login or register to post comments
     

    Related

    • Sequanon’s Test for Down Syndrome Raises Hopes and Questions

      While the test may reduce the need for riskier invasive procedures such as amniocentesis, it also raises ethical issues.

    • Sequenom’s Test for Down Syndrome Raises Hopes and Questions

      While the test may reduce the need for riskier invasive procedures such as amniocentesis, it also raises ethical issues.

    • Sequenom Announces a Launch Date For Its Non-Invasive Down Syndrome Test

      Prohost Biotech submits: When Sequenom (SQNM) was welcoming analysts and shareholders who are “interested in discussing the results for the first quarter of 2011,” the firm’s CEO was quite aware that most attendees were, in fact, much more interested in the progress of the firm’s plans for the non-invasive prenatal tests, especially the Down Syndrome test.

    • DNA blood test cuts invasive testing for Down's syndrome

      DNA in a pregnant woman's blood can reliably show whether her foetus has Down's syndrome, thus hugely reducing the need for invasive test procedures such as amniocentesis, research published on Tuesday said.Down's syndrome, a major developmental disorder also called trisomy 21, occurs in around one in every 800 live births.Pre-natal diagnosis mainly entails sampling fluid, drawn by a needle, from the amniotic sac enveloping the foetus. Another technique is called chorionic villus sampling, and entails taking a sample of placenta.

    • IVF and Down's syndrome: New test raises questions

      A test designed to spot chromosome abnormalities in eggs could be a "revolution" in fertility, helping older women determine their chances of having an IVF baby, doctors said on Monday.But in developing the test, they added, worrying evidence emerged that in-vitro fertilisation (IVF) may boost the risk of a baby with Down's syndrome.

    • Down's syndrome test breakthrough 'on the horizon'

      A less risky non-invasive procedure based on maternal DNA to diagnose Down's syndrome could be generally available to pregnant women by 2013, a Cyprus researcher said Tuesday."Down's Syndrome, or Trisomy 21, is the most common cause of mental retardation with an incidence of one in 600 births," Philippos Patsalis of the Institute of Neurology and Genetics in Nicosia told reporters."This method can apply to all pregnancies not only those at risk," he added, describing it as "one of the most important milestones in the history of the institute."

    • Via Government’s Fiscal Policy and Regulatory Oversight, Ethical Values Shape Monetary Value

      Yves here. NC guest writer Doug Smith also dug into these issues in his book Of Value and Values.

    • Prescriptions Blog: The Quandary Posed by a New Down Syndrome Test

      Advocates are concerned that a non-invasive test to determine if a fetus has Down syndrome will lead to more pregnancies being terminated.

    • On Bryan Caplan's ethical intuitionism

      Bryan offers the most extensive version of his view I've seen him blog.  On overall method and meta-ethics, I'm not so far from Bryan (and someday he will get a post in praise of him).  But I usually disagree with his applications of the method.  For instance he seems to argue that because employees are allowed to discriminate against employers, we should allow for a reciprocal right of employer discrimination.

    • Spy agencies scrounge for details on North Korean nuclear test as no traces of nuclear particles found

      CLICK TO ENLARGENorth Korea is believed to have more than 800 ballistic missiles. What does it plan to do with them? WASHINGTON/SEOUL, Feb 20- U.S.

    Latest

    Campaigns Panel: Stars who offend
    Campaigns Panel: Stars who offend
    Eurozone Manufacturing Data Comes In Better-Than-Expected, But Still Ugly
    Eurozone Manufacturing Data Comes In Better-Than-...

    User login

    • Create new account
    • Request new password
    • Click on the icon to sign in with your social network login or enter your Bullfax.com login

    Our Blog

    • IMF calls on Osborne to spend on infrastructure
    • ICBC/Goldman Sachs: farewell
    • Japan’s budget deficit, Rolls-Royce, Raytheon and Sony in Our Daily Round-Up for 05/22/2013

    Markets Map

    Markets Map

    Follow Us

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS
    S&P 500: 1655.35 -0.83% FTSE: 6713.40 -1.89% Nikk.: 14483.98 -7.89% DAX: 8312.64 -2.63% HSI: 22669.68 -2.61% FX: EUR/GBP: 1.1691 USD/EUR: 1.2895 JPY/USD: 101.075 Commodities: Gold: 1388.45

    Bullfax.com - Market News & Analysis 2008-2011
    Contact Us | About Us | Terms & Conditions

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS .

    Secondary menu

    • Latest News
    • Top Rated
    • Most Popular
    • Archive
    • Discussions